You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 9, September 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Gallbladder Carcinoma in the Era of Laparoscopic Cholecystectomy

Koji Yamaguchi, MD; Kazuo Chijiiwa, MD; Hitoshi Ichimiya, MD; Masayuki Sada, MD; Katsuhiko Kawakami, MD; Fujihiko Nishikata, MD; Kohki Konomi, MD; Masao Tanaka, MD

Arch Surg. 1996;131(9):981-984.


Abstract

Objective
To assess the usefulness of laparoscopic cholecystectomy for unsuspected and suspected gallbladder carcinoma.

Design
Retrospective review with a mean follow-up of 27 months, ranging from 1 to 47 months.

Setting
University hospital and 8 affiliated hospitals.

Patients
Of 2616 laparoscopic cholecystectomies performed over 4 years, 24 gallbladder carcinomas were treated by laparoscopic cholecystectomy and retrospectively reviewed.

Results
The clinical course depended on the histopathologic depth of invasion of gallbladder carcinoma. All 6 cases of pathologic tumor (pT) stage in situ (pTis) gallbladder carcinoma and 2 cases of pT1 gallbladder carcinoma showed no invasion to the lymphatic, venous, or perineural spaces, and these 8 patients were all doing well from 2 to 19 months (mean, 11 months) after laparoscopic cholecystectomy. Sixteen cases of pT2 or pT3 gallbladder carcinoma invaded the subserosal layer or the liver, and 5 of the 16 patients were dead of liver dysfunction, abdominal wound recurrence, or liver metastasis 5 days and 7, 12, 15, and 18 months after operation, although additional resection of the liver bed with lymph node dissection was performed after laparoscopic cholecystectomy in 4 of these 5 patients. Abdominal wall recurrence in the absence of distant metastasis was present in 3 (19%) of the 16 patients with pT2 or pT3 gallbladder carcinoma due to inoculation of cancer cells in the abdominal stab wounds where the gallbladder or laparoscope was removed.

Conclusions
Gallbladder carcinoma at the pTis or pT1 stage removed laparoscopically needs no other treatment. We recommend that the gallbladder be removed by vinyl bag and port sites be excised or washed with normal saline to prevent port site recurrence in patients with laparoscopic cholecystectomy for pT2 or pT3 carcinoma.

Arch Surg. 1996;131:981-984



Author Affiliations

From the Department of Surgery I, Kyushu University Faculty of Medicine, (Drs Yamaguchi, Chijiiwa, and Tanaka), Department of Surgery, Hamanomachi Hospital (Dr Ichimiya) and Sada Hospital (Dr Sada), Fukuoka, Japan; and National Kokura Hospital (Dr Kawakami), Kosei Nennkin Hospital (Dr Nishikata), and Kyushu Rosai Hospital (Dr Konomi), Kitakyushu, Japan.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Recurrent Gallbladder Carcinoma along Laparoscopic Cholecystectomy Port Tracks: CT Demonstration
Winston et al.
Radiology 1999;212:439-444.
ABSTRACT | FULL TEXT  

The Management of Gallbladder Cancer: Before, During, and After Laparoscopic Cholecystectomy
Pearlstone et al.
SURG INNOV 1998;5:121-128.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.